A PHASE 2, DOUBLE BLIND, MULTI CENTER, RANDOMIZED STUDY COMPARING TENOFOVIR DISOPROXIL FUMARATE, EMTRICITABINE PLUS TENOFOVIR DISOPROXIL FUMARATE, AND ENTOCAVIR IN THE TREATMENT OF CHRONIC HEPATITIS B SUBJECTS WITH DECOMPENSATED LIVER DISEASE AND IN THE P